Mitchell L De Snoo, Erik L Friesen, Yu Tong Zhang, Rebecca Earnshaw, Geneviève Dorval, Minesh Kapadia, Darren M O'Hara, Victoria Agapova, Hien Chau, Ornella Pellerito, Matthew Y Tang, Xinzhu Wang, Gerold Schmitt-Ulms, Thomas M Durcan, Edward A Fon, Lorraine V Kalia, Suneil K Kalia
As pathogenic Parkin mutations result in the defective clearance of damaged mitochondria, Parkin-dependent mitophagy is thought to be protective against the dopaminergic neurodegeneration observed in Parkinson's disease. Recent studies, however, have demonstrated that Parkin can promote cell death in the context of severe mitochondrial damage by degrading the pro-survival Bcl-2 family member, Mcl-1. Therefore, Parkin may act as a 'switch' that can shift the balance between protective or pro-death pathways depending on the degree of mitochondrial damage...
December 2, 2019: Cell Death & Disease